New Blood Test Could Detect Pancreatic Cancer Earlier
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
Interesting Engineering6 天
New blood test identifies elusive pancreatic cancer way before symptoms appear
New blood test PAC-MANN detects pancreatic cancer early with 98% accuracy, offering hope for improved survival rates.
Medscape1 天
Identifying Pancreatic Cancer Remains Elusive. Here’s Why.
The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.
Most pancreatic cancer isn’t caught until it’s late stage — a new blood test could ...
The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...
生物通6 天
探索胰腺癌耐药机制：ACOT8 的关键作用与联合治疗新希望
诱导 PDAC 细胞铁死亡可降低由 ACOT8 高表达引起的吉西他滨耐药性 ：研究人员将吉西他滨与铁死亡诱导剂 erastin 联合处理细胞， 实验显示联合处理显著降低了细胞对吉西他滨的耐药性，ACOT8 表达的细胞和类器官模型的生长也受到明显抑制。这表明 ACOT8 的抗铁死亡作用是导致吉西他滨耐药的关键因素。
来自MSN4 天
Blood Test for Early Pancreatic Cancer Shows Promise
He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...
Blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...
News Medical on MSN7 天
New immune map uncovers key pancreatic cancer insights
Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...
Mena FN7 天
Pancreatic Ductal Adenocarcinoma Market Set For Significant Expansion By 2032 Delveinsight
LAS VEGAS , NV, UNITED STATES, February 12, 2025 /EINPresswire / -- DelveInsight's“Pancreatic Ductal Adenocarcinoma market Insights, Epidemiology, and Market Forecast-2032” report offers an in ...